Proteasome Inhibitor-Associated Thrombotic Microangiopathy: A Review of Cases Reported to the FDA Adverse Event Reporting System and Published in the Literature
American Journal of Hematology - United States
doi 10.1002/ajh.25832
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 15, 2020
Authors
Publisher
Wiley